Cargando…
Identifying advanced MAFLD in a cohort of T2DM and clinical features
BACKGROUND: MAFLD is the most common cause of chronic liver disease, affecting 25% of the global population. Patients with T2DM have an increased risk of developing MAFLD. In addition, patients with T2DM have a higher risk of advanced forms of steatohepatitis and fibrosis. Identifying those patients...
Autores principales: | Sanchez-Bao, Ana Maria, Soto-Gonzalez, Alfonso, Delgado-Blanco, Manuel, Balboa-Barreiro, Vanesa, Bellido, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992874/ https://www.ncbi.nlm.nih.gov/pubmed/36909342 http://dx.doi.org/10.3389/fendo.2023.1058995 |
Ejemplares similares
-
Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023) -
Mining Gut Microbiota From Bariatric Surgery for MAFLD
por: Wu, Wei-Kai, et al.
Publicado: (2021) -
TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
por: Shepard, Christopher R.
Publicado: (2021) -
Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022) -
Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis
por: Luo, Kuanhong, et al.
Publicado: (2023)